Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

MGI Starts Aquavan Phase III Program For Small Surgeries

March 22, 2006

By Jennifer Boggs

Novavax Boosts Vaccines With $38M Public Offering

March 22, 2006

By Jennifer Boggs

Novavax Boosts Vaccines With $38M Public Offering

March 22, 2006

By Jennifer Boggs

MGI Starts Aquavan Phase III Program For Small Surgeries

March 22, 2006

By Jennifer Boggs

PTC, Schering Sign $200M Preclinical HCV Partnership

March 21, 2006

By Jennifer Boggs

PTC, Schering Sign $200M Preclinical HCV Partnership

March 21, 2006

By Jennifer Boggs

Restructuring Gets Stressgen C$9M For HspE7 Development

March 20, 2006

By Jennifer Boggs

Restructuring Gets Stressgen C$9M For HspE7 Development

March 20, 2006

By Jennifer Boggs

Chiron Pulls Measles Vaccine Off Developing World Market

March 17, 2006

By Jennifer Boggs

Chiron Pulls Measles Vaccine Off Developing World Market

March 17, 2006

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...